Celadon Pharmaceuticals PLC (CEL) — Net Asset Momentum
Celadon Pharmaceuticals PLC (CEL) recorded a net asset momentum of -54.8% as of December 2023, with net assets of GBX3.18 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See CEL defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Celadon Pharmaceuticals PLC Net Asset Momentum (2019–2023)
This chart tracks Celadon Pharmaceuticals PLC's year-over-year net asset growth across 5 annual reporting periods from 2019 to 2023. The most recent momentum reading is -54.8%, with net assets of GBX3.18 Million GBX as of December 2023. Read Celadon Pharmaceuticals PLC (CEL) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Celadon Pharmaceuticals PLC (2019–2023)
The table below shows the complete annual net asset history for Celadon Pharmaceuticals PLC from 2019 to 2023, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Celadon Pharmaceuticals PLC market capitalisation.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | GBX3.18 Million | GBX9.22 Million | GBX6.04 Million | ▼ -54.8% |
| 2022 | GBX7.04 Million | GBX13.25 Million | GBX6.21 Million | ▲ +9.8% |
| 2021 | GBX6.41 Million | GBX6.61 Million | GBX197.23K | ▲ +6373.2% |
| 2020 | GBX99.03K | GBX3.85 Million | GBX3.75 Million | ▲ +187.3% |
| 2019 | GBX-113.47K | GBX2.49 Million | GBX2.60 Million | — |